- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03767556
Effects of Respiratory Muscle Training in Obese Women
July 22, 2019 updated by: Eli Maria Pazzianotto Forti, Universidade Metodista de Piracicaba
Effects of Respiratory Muscle Training on Lung Function, Respiratory Muscle Function and Physical Fitness in Obese Women
The objective of this study will be to evaluate the effects of inspiratory muscle training (IMT) on the physical fitness of obese women
It is believed that the application of these exercises helps in the improvement of inspiratory muscle performance, which should improve physical fitness and thus allow a better performance in the activities of daily living.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This is a clinical trial, in which adult obese volunteers aged 20-59 years will be evaluated, which will be randomized into two groups: training group (GT) and control group (CG).
Both groups should meet the following inclusion criteria: Age between 20 and 59 years, BMI> 35 and <55 kg / m², with clinical stability, able to perform the physical tests and acceptance to participate in the study.
Women with reports of decompensated heart disease, chronic obstructive pulmonary disease and asthma will be excluded; musculoskeletal and / or neuromuscular changes, which make it impossible to perform the tests.
The evaluations will occur in two days with at least 48 hours of interval between them, within a period of seven days, before and after the respiratory muscle training of four weeks.
In addition to anamnesis, the initial evaluation will include assessment of pulmonary function (SLF, forced vital capacity (FVC) and maximal voluntary ventilation (VVM)) by spirometry; respiratory muscle evaluation through the measures of Maximum Inspiratory Pressure (PIMax) and maximal sustained inspiratory pressure (PIMaxS); physical fitness assessment through the 6-minute step test (TD6), incremental shuttle walking test (ISWT) and Sentar e Levantar (SL) test, as well as assessment of dyspnea.
For the TMI will be used equipment with pressure threshold pressure.
During the 4-week period, the IMT will be performed 5 days a week and will consist of 2 series with 30 inspirations.
Inspirations will be performed slowly and protracted.
The training load will be 55% of the PIMáx readjusted weekly.
Statistical analysis will be performed using BioEstat version 5.3.
To evaluate the normality of distribution of the data will be used Shapiro-Wilk test.
For the comparison of all variables studied, the Student's t-test or the Mann-Wittney test will be used.
Pre- and post-training parametric results will also be compared statistically using variance analyzes of two variables (group × time) (ANOVA).
Bonferroni tests will be used to examine differences between groups when indicated by ANOVA.
The significance level of 5% will be adopted for all analyzes (P <0.05) where the data will be expressed as mean and standard deviation.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
São Paulo
-
Piracicaba, São Paulo, Brazil, 13400911
- Universidade Metodista de Piracicaba (UNIMEP)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 59 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- BMI> 35 and <55 kg / m²
- with clinical stability
- suitable for physical tests
- acceptance to participate in the study
Exclusion Criteria:
- women with reports of decompensated heart disease
- chronic obstructive pulmonary disease and asthma
- musculoskeletal and / or neuromuscular changes,
- which make it impossible to perform the tests.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
This group will not receive intervention
|
|
|
Experimental: Inspiratory Muscle Training
This group, for inspiratory muscle training, will use the Powerbreathe® K5 device.
This device will be adjusted with a load of 55% of previously assessed MIP.
The volunteer will be instructed to inhale with sufficient force to overcome the resistance of the equipment and subsequently perform a normal expiration.
During the 4-week period of respiratory muscle training volunteers will be instructed to perform 2 sets with 30 inspiratory efforts, 5 days a week.
The training load will be readjusted on the first day of training each week, after a new reassessment of the PIMax in order to guarantee the overload during inspiratory muscle training.
|
Powerbreathe® K5
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EVALUATION OF LUNG VOLUMES AND CAPACITIES
Time Frame: before and after the intervention, for 2 days with a 72-hour interval
|
Spirometry will be out according to the guidelines of the American Thoracic Society (ATS) and European Respiratory Society (ERS) (2005).
The values extracted will be selected according to Pereira (2002), and the predicted values calculated using the equation proposed by Pereira et al. (1992) for Brazilians.
|
before and after the intervention, for 2 days with a 72-hour interval
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
EVALUATION OF PHYSICAL ACTIVITY LEVEL
Time Frame: before and after the intervention, for 2 days with a 72-hour interval
|
Volunteers will respond to the International Physical Activity Questionnaire, which is an instrument that allows estimating the weekly time spent in physical activity.
The final classification given by the International Physical Activity Questionnaire occurs in five levels of physical activity: Very Active, Active, Irregularly active and Sedentary.
|
before and after the intervention, for 2 days with a 72-hour interval
|
|
6-MINUTE DEGREE TEST (TD6)
Time Frame: before and after the intervention, for 2 days with a 72-hour interval
|
The TD6 will be used for the evaluation of cardiorespiratory fitness by calculating the maximum oxygen consumption (VO2 max) in an indirect way and the functional capacity of the volunteers.
The TD6 outcome will be the number of volunteer climbs on the rung (PESSOA et al., 2015).
The values reached in the number and the rhythm of ascents in the step will express the functional capacity.
|
before and after the intervention, for 2 days with a 72-hour interval
|
|
INCREMENTAL SHUTTLE WALKING TEST (ISWT)
Time Frame: before and after the intervention, for 2 days with a 72-hour interval
|
The ISWT will be used to determine the functional capacity of the volunteers by the distance traveled during the test.
It is a walking test, with progressive loading, given by the increase in walking speed required to overcome each stage of the test.
The ISWT will be controlled by specific software, which determines the speed and pace of each stage of the test.
This test will be carried out in a corridor in which 10 meters in length, delimited by cones, at each end, will be demarcated by volunteers, obeying each sound signal programmed by Sing et al. (1992).
The test will be terminated at the signal of inability to continue or non-accompaniment of speeds by the volunteer.
|
before and after the intervention, for 2 days with a 72-hour interval
|
|
TEST TO SIT AND LIFT
Time Frame: before and after the intervention, for 2 days with a 72-hour interval
|
This test will be used to determine the indirect force in the lower limbs.
To perform this test, a chair with a height of 40 cm will be used, with backrest, in which the volunteer will begin the test in the sitting position, in the middle of the seat, with the spine erect, feet resting on the floor and the arms crossed against the thorax.
At the investigator's signal, the volunteer should stand up, stand fully up, and then return to the seated position.
Volunteers will be encouraged to sit and stand up as often as possible in 30 seconds.
The result will be determined by counting the number of times the volunteer correctly performed the movements of sitting and lifting of the chair without the aid of the movement of the upper limbs
|
before and after the intervention, for 2 days with a 72-hour interval
|
|
EVALUATION OF INSPIRATORY MUSCLE STRENGTH
Time Frame: before and after the intervention, for 2 days with a 72-hour interval
|
The Maximum Inspiratory Pressure (PIMax) and Maximum Expiratory Pressure (PEMax) measurements will be performed.
The measures of the MIP will aim beyond the evaluation of the strength of the respiratory muscles, establish the initial load of the resistance test of the respiratory muscles as well as the training load.
The measurements of PImax and PEmax, will be evaluated through an analog manovacuometer.
Each participant should perform three to five maximum inspiratory and reproducible inspiratory efforts provided there has been a maximum difference of 10% between them being the highest value considered for statistical analysis.
The time interval between consecutive measurements was 1 minute.
|
before and after the intervention, for 2 days with a 72-hour interval
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Eli M Pazzianoto-Forti, Phd, Universidade Metodista de Piracicaba
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2018
Primary Completion (Actual)
May 21, 2019
Study Completion (Actual)
June 8, 2019
Study Registration Dates
First Submitted
October 17, 2018
First Submitted That Met QC Criteria
December 5, 2018
First Posted (Actual)
December 6, 2018
Study Record Updates
Last Update Posted (Actual)
July 24, 2019
Last Update Submitted That Met QC Criteria
July 22, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Tamires2018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
Clinical Trials on Inspiratory muscle training
-
Ceren Derya GültekinRecruitingPulmonary Rehabilitation | Inspiratory Muscle Training | Hematopoietic Stem Cell Transplantation (HSCT)Turkey
-
Elisabethinen HospitalUnknownStem Cell Transplantation | Inspiratory Muscle Training | Respiratory Muscle TrainingAustria
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Istinye UniversityCompletedStroke | Respiratory MusclesTurkey
-
Dokuz Eylul UniversityDokuz Eylül University, Scientific Research Projects Coordination UnitCompleted
-
University of British ColumbiaNatural Sciences and Engineering Research Council, CanadaCompletedRespiratory Muscles | Breathing ExercisesCanada
-
Universidad Francisco de VitoriaNot yet recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric Health
-
Universidad Francisco de VitoriaActive, not recruitingFrailty Syndrome | Respiratory Muscle Weakness | Age-Related Frailty | Geriatric HealthSpain
-
King Saud UniversityCompleted
-
Hong Kong Metropolitan UniversityNot yet recruiting